°øÁö : µµÄìÁõ±Ç°Å·¡¼Ò JASDAQ ½ºÅÄ´Ùµå ½ÃÀå ½Å±Ô »óÀå °ü·Ã ¾È³»

Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | ºñ±³¸®½ºÆ®

Pink Sheet : ÀÇ·á Á¤Ã¥ ¹× ÀÇ·á ±ÔÁ¦¿¡ °üÇÑ Á¤º¸ ¼­ºñ½º

Pink Sheet

¸®¼­Ä¡»ç Pink Sheet
¹ßÇàÁ¤º¸ ¿¬°£±¸µ¶ »óǰ ÄÚµå 398015
ÆäÀÌÁö Á¤º¸ ¿µ¹®
°¡°Ý
ÀÚ¼¼ÇÑ ³»¿ëÀº ¹®Àǹٶø´Ï´Ù.

Pink Sheet : ÀÇ·á Á¤Ã¥ ¹× ÀÇ·á ±ÔÁ¦¿¡ °üÇÑ Á¤º¸ ¼­ºñ½º Pink Sheet
¹ßÇàÁ¤º¸ : ÆäÀÌÁö Á¤º¸ : ¿µ¹®

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±Û·Î¹ú Á¤Ã¥ ¹× ±ÔÁ¦¿¡ È®½ÇÈ÷ ´ëÀÀÇϱâ À§Çؼ­´Â µ¿Çâ¿¡ °üÇÑ Á¤º¸ÀÇ ÆÄ¾ÇÀÌ Áß¿äÇÕ´Ï´Ù. ±ÔÁ¦ ȯ°æÀº Ç×»ó º¯È­Çϰí ÀÖÀ¸¸ç, Ãֽе¿ÇâÀ» Áö¼ÓÀûÀ¸·Î ÆÄ¾ÇÇÏ´Â °ÍÀº ¾î·Á¿ï ¼öµµ ÀÖ½À´Ï´Ù. ¹ý±ÔÁ¦»ó º¯°æÀÌ ÄÄÇöóÀ̾𽺠¹× ¸®½ºÅ© °èȹÀÇ ÀԾȿ¡ ¹ÌÄ¥ ¼ö ÀÖ´Â ¿µÇâÀ» ¿¹ÃøÇÏ´Â °ÍÀº ´õ¿í ´õ ¾î·Á¿öÁö°í ÀÖ½À´Ï´Ù.

º» ¿¬°£Á¤º¸¼­ºñ½º¿¡¼­´Â 100³â ÀÌ»ó ÄÄÇöóÀ̾ð½º, ¹ý·ü, ÀÇ·á Á¤Ã¥ ¹× ±ÔÁ¦°¡ º¹ÀâÇÏ°Ô °ü·ÃµÇ¾î ÀÖ´Â ÇöȲ¿¡ ´ëÀÀÇϱâ À§ÇØ ´º½º Çìµå¶óÀÎ ÀÌ»óÀÇ ºÐ¼®±îÁö Á¦°øÇϸç, À¯ÀÍÇÑ ÃֽаßÇØ¸¦ ÀüÇØµå¸³´Ï´Ù. 20¿© ¸íÀÇ ¾Ö³Î¸®½ºÆ®, ¾÷°è Àü¹®°¡, ¾÷°è ¸®´õÀÇ ±Û·Î¹ú ³×Æ®¿öÅ©¿¡ ÀÇÇØ Á¦Ç°ÀÇ ½Åû¿¡¼­ ½ÂÀαîÁöÀÇ ÁøÃ´À» Áö¼ÓÀûÀ¸·Î ÃßÀûÇϸ鼭 °úÁ¦¸¦ ¿¹ÃøÇϰí, ¸®½ºÅ©¸¦ ÃÖ¼ÒÇÑÀ¸·Î ¾ïÁ¦ÇÏ¸ç ±âȸ¸¦ ÃÖ´ëÇÑ È°¿ëÇÏ´Â ¹æ¹ý¿¡ ´ëÇØ µ¶ÀÚÀûÀÎ °´°üÀû Àü¸ÁÀ» Á¦½ÃÇÕ´Ï´Ù. º» ¼­ºñ½º´Â ¾ÈÀüÇÑ ÀÓ»ó½ÃÇèÀÇ °èȹ ¹× ½ÃÇà, Á¤º¸¿¡ ±â¹ÝÇÏ´Â °áÁ¤À» À§ÇÑ ÀÇ·á Á¤Ã¥ ¹× ±ÔÁ¦ÀÇ µ¿Çâ ÃßÀûÀ» °­·ÂÈ÷ Áö¿øÇÕ´Ï´Ù.

Pink SheetÀÇ Æ¯Â¡

  • 20¸í ÀÌ»óÀÇ ¾Ö³Î¸®½ºÆ®°¡ °ø°³ÇÏ´Â ½Ç½Ã°£ ºÐ¼®¿¡ ¸ð¹ÙÀÏ, ÅÂºí¸´, PC·Î ¾×¼¼½º °¡´É
  • ±ÔÁ¦ ¹× »óȯ Á¤Ã¥, ¹ý·É°ú ÄÄÇöóÀ̾ð½º, ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ¿¡ °üÇÑ ½Ç½Ã°£ ´º½º, ºÐ¼®, °ßÇØ
  • FDAÀÇ µ¿Çâ ÃßÀû : ÁÖ¿ä ±ÔÁ¦ÀÇ ¸¶ÀϽºÅæ, °æÀï ºÐ¼®, ÃֽаæÇâ¿¡ ´ëÇØ Ç×»ó ÃֽŠÁ¤º¸¸¦ ÆÄ¾ÇÇϱâ À§ÇÑ µ¶ÀÚÀûÀÎ µ¥ÀÌÅÍ ¹× Á¦Ç°ÀÇ ½Åû¿¡¼­ ½ÂÀαîÁöÀÇ ÁøÃ´À» ºÐ·ùÇÑ ¾ç¹æÇâ Â÷Æ® ¼öÁý
  • ¸Å¿ù ÀǾàǰ ½É»ç °³¿ä - ½É»ç°úÁ¤ÀÇ ÁÖ¿ä ÀλçÀÌÆ®¿Í ÇÔ²² FDA ½ÂÀÎ °áÁ¤À» ½ÉÃþ 'ȸ°í'
  • Àü¹®°¡ ÀλçÀÌÆ® - ÁÖ¿ä ÀÓ¿ø ¹× Á¤Ã¥ ÀÔ¾ÈÀÚ¿ÍÀÇ ÀÎÅͺä, ¾÷°è ¸®´õ·ÎºÎÅÍÀÇ µ¶Á¡Àû ÇØ¼³
  • ¼¼°èÀûÀΠó¹æ ÀǾàǰ ¹× ½ÃÆÇ(OTC) ÀǾàǰ, Á¦Á¶¸¦ ´Ù·ç°í, Á¦Ç° °³¹ß°ú ÄÄÇöóÀ̾𽺠°èȹÀ» º¸´Ù È¿À²ÀûÀ¸·Î ½ÃÇàÇϱâ À§ÇØ ¾÷°èÀÇ ¸ðµç ºÎºÐ ¹× ´Ù¸¥ ±ÔÁ¦±â°üÀÇ Â÷ÀÌÁ¡°ú °øÅëÁ¡¿¡ °üÇÑ µ¶ÀÚÀû Àü¸Á Á¦°ø
  • ºñó¹æÀü ÀǾàǰ ¹× ¿µ¾çº¸Á¶½Äǰ ¾÷°èÀÇ Á¤º¸
  • ¹Ì±¹ ¹× ±¹Á¦ÀûÀÎ ÀǾàǰ Á¦Á¶¿¡¼­ QA/QCÀÇ ¿ä°Ç, ºñ¿ë »è°¨¿¡ °üÇÑ ÀλçÀÌÆ®, º£½ºÆ® ÇÁ·¢Æ¼½º ÇÁ·Î¼¼½º Áؼö¸¦ À§ÇØ À¯¿ëÇÑ º»ÁúÀ» ÆÄ¾ÇÇÑ ºÐ¼®
KSA 16.12.22

Keep your finger on the pulse of global policy and regulatory developments in the Pharmaceutical and Healthcare industry

With the regulatory environment changing constantly, it can be challenging to find a reliable comprehensive source of information to keep up-to-date. Furthermore, it's becoming increasingly challenging to predict the implications that legislative and regulatory changes that impact the ever evolving Pharmaceutical industry. What you need is a source that you are confident has the latest news, analysis and a perspective that enables you to quickly understand developments and impacts on your day to day. Pink Sheet is the answer!

For over 100 years, Pink Sheet continues to bring fresh, meaningful opinion and analysis that goes beyond the headlines to help you navigate the complex world of compliance, legislation and policy and regulation. Our global network of over 20 analysts, industry experts and thought leaders continually track product progress from submission to approval and bring an original and objective perspective of how to anticipate challenges, minimize risks, and maximize opportunities.

Here is what you can expect:

  • Over 20 global analysts publishing real-time analysis accessible on mobile, tablet and PC.
  • Real time news, analysis and opinion on regulation and reimbursement policy, legislation and compliance and the implications to the market.
  • FDA Performance Tracker: proprietary data and collection of interactive charts that catalogue a product's progress from submission to approval to keep you updated on key regulatory milestones, competitive analysis, and the latest trends.
  • Monthly Drug Review Profile - in depth “look behind” FDA approval decisions with key insights on lessons learned
  • Expert Insights - Interviews with key executives, and policymakers, and exclusive commentary from thought leaders
  • Global coverage of Rx and Over-the-Counter (OTC) medicines and manufacturing provide a unique perspective of all parts of the industry and how requirements by different regulatory authorities differ or overlap for more efficient product development and compliance planning.
  • Intelligence from the non-prescription pharma and dietary supplement industries.
  • Insightful analysis to help in complying with U.S and international pharmaceutical manufacturing QA/QC requirements, cost cutting insights, best practice processes.
Back to Top
ÀüÈ­ ¹®ÀÇ
F A Q